This inventor holds 1 USPTO granted patent. Top assignee: Kyoritsu Seiyaku Corporation. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Ken-ichi Asai: Innovator in Mucosal Adjuvant Composition
Introduction
Ken-ichi Asai is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of immunology through his innovative work on mucosal adjuvants. His research focuses on enhancing immunity at the surface of mucous membranes, which is crucial for preventing trans-mucosal infections.
Latest Patents
Ken-ichi Asai holds a patent for a mucosal adjuvant composition. This invention addresses the need for a novel mucosal adjuvant that can enhance immunity when administered to non-human animals. The composition includes molecules with a molecular weight ranging from 100 to 300 kDa, obtained from cells or culture fluid. By administering this composition alongside an inactivated vaccine, the preventive effects against various trans-mucosal infections can be significantly increased.
Career Highlights
Asai is associated with Kyoritsu Seiyaku Corporation, where he continues to develop innovative solutions in the field of veterinary medicine. His work is particularly relevant for preventing infections in canines, including those caused by viruses such as canine parainfluenza and canine distemper.
Collaborations
Ken-ichi Asai has collaborated with notable colleagues, including Kazuo Kawakami and Masami Mochizuki. Their combined expertise contributes to the advancement of research in mucosal adjuvants and immunology.
Conclusion
Ken-ichi Asai's contributions to the field of mucosal adjuvants represent a significant advancement in veterinary medicine. His innovative approach to enhancing immunity through his patented composition is poised to make a lasting impact on the prevention of trans-mucosal infections in animals.